MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$171,591K
(63.12%↑ Y/Y)
Trade receivables
$109,272K
(17.00%↑ Y/Y)
Short-term investments
$66,809K
(-64.82%↓ Y/Y)
Prepaid expenses and
other current assets
$19,114K
(33.41%↑ Y/Y)
Inventory, net
$5,985K
(-12.92%↓ Y/Y)
Restricted cash
$854K
(193.47%↑ Y/Y)
Total current assets
$373,625K
(-8.87%↓ Y/Y)
Long-term inventory, net
$28,176K
(12.27%↑ Y/Y)
Long-term investments
$20,569K
(0.10%↑ Y/Y)
Other assets
$19,697K
(306.12%↑ Y/Y)
Right of use assets,
net
$13,617K
(13.65%↑ Y/Y)
Property and equipment,
net
$9,368K
(23.38%↑ Y/Y)
Total assets
$465,052K
(-3.12%↓ Y/Y)
Accumulated deficit
-$2,227,991K
(-25.87%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$368K
(-132.51%↓ Y/Y)
Total liabilities and
stockholders deficit
$465,052K
(-3.12%↓ Y/Y)
Total stockholders
deficit
-$553,843K
(-22.55%↓ Y/Y)
Additional paid-in capital
$1,671,976K
(27.16%↑ Y/Y)
Common stock, 0.01 par
value shares...
$2,540K
(21.41%↑ Y/Y)
Total liabilities
$1,018,895K
(9.33%↑ Y/Y)
Royalty financing
obligations
$407,181K
(-12.74%↓ Y/Y)
Secured term loan
$395,197K
(25.30%↑ Y/Y)
Total current
liabilities
$195,391K
(39.71%↑ Y/Y)
Operating lease
liabilities
$11,122K
(42.97%↑ Y/Y)
Deferred revenue
$8,831K
Finance lease
liabilities
$1,173K
(-49.31%↓ Y/Y)
Accrued expenses
$119,398K
(28.89%↑ Y/Y)
Royalty financing
obligations
$40,317K
(17.53%↑ Y/Y)
Share-based liability
$16,216K
Accounts payable
$10,958K
(9.05%↑ Y/Y)
Deferred revenue
$5,409K
Operating lease
liabilities
$1,858K
(73.48%↑ Y/Y)
Finance lease
liabilities
$1,235K
(-31.20%↓ Y/Y)
Back
Back
Balance Sheet
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)
source: myfinsight.com